News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Nature Reviews Drug Discovery Release: 2003 Approvals: A Year Of Innovation And Upward Trends
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Although the number of new molecular entities approved in 2003 was only marginally higher than in 2002, approvals for innovative drugs were encouraging.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Immuno-oncology
J&J Wins Third National Priority Approval for Multiple Myeloma Combo
March 6, 2026
·
2 min read
·
Tristan Manalac
Huntington’s disease
FDA Official Fires Back at UniQure, Doubles Down on Sham-Controlled Trial
March 6, 2026
·
2 min read
·
Tristan Manalac
FDA
FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic
March 5, 2026
·
2 min read
·
Tristan Manalac
Regulatory
PepGen’s Mid-Stage Myotonic Dystrophy Study Hit With ‘Surprise’ Pause
March 5, 2026
·
2 min read
·
Tristan Manalac